LaunchPad Lands Coveted Grant for Dental Bone Graft

In more than 30% of dental implant cases, existing bone graft materials fail to achieve the desired clinical results, and another bone graft procedure must be conducted, increasing the overall time and cost of the treatment. That's where LaunchPad Medical could potentially change the game with its new dental bone graft solution based on the company's Tetranite technology. The Lowell, MA-based company won a $1.8 million grant from the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center to initiate a pivotal animal study of its technology. The grant was funded by the National Institutes of Health's National Institute of Dental and Cranial Research to improve the translation of promising tissue engineering and regenerative medicine technologies for dental, oral, and craniofacial clinical practice. This isn't the company's first win, either. Previously, LaunchPad won two prior grants from the same center. The current grant, the largest of the three, is expected to support a pivotal animal study and generate enough data to file an investigational device exemption application with FDA to start a clinical trial. "Unlike most exiting dental bone graft materials, this enhanced formulation of Tetranite resorbs and is replaced by bone on a timescale commensurate with existing graft materials but does not require ancillary containment devices like membranes or meshes or fixation aids like tacks and screws," said Joseph P. Fiorellini, professor and director of the p...
Source: MDDI - Category: Medical Devices Authors: Tags: R & D Implants Source Type: news